These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Association of carmustine with a lipid emulsion: in vitro, in vivo and preliminary studies in cancer patients. Maranhão RC, Graziani SR, Yamaguchi N, Melo RF, Latrilha MC, Rodrigues DG, Couto RD, Schreier S, Buzaid AC. Cancer Chemother Pharmacol; 2002 Jun; 49(6):487-98. PubMed ID: 12107554 [Abstract] [Full Text] [Related]
7. Delivery of daunorubicin to cancer cells with decreased toxicity by association with a lipidic nanoemulsion that binds to LDL receptors. Teixeira RS, Valduga CJ, Benvenutti LA, Schreier S, Maranhão RC. J Pharm Pharmacol; 2008 Oct; 60(10):1287-95. PubMed ID: 18812021 [Abstract] [Full Text] [Related]
9. Effects on Walker 256 tumour of carmustine associated with a cholesterol-rich microemulsion (LDE). Teixeira RS, Curi R, Maranhão RC. J Pharm Pharmacol; 2004 Jul; 56(7):909-14. PubMed ID: 15233870 [Abstract] [Full Text] [Related]
10. Plasma kinetics of a cholesterol-rich microemulsion (LDE) in patients with Hodgkin's and non-Hodgkin's lymphoma and a preliminary study on the toxicity of etoposide associated with LDE. Pinheiro KV, Hungria VT, Ficker ES, Valduga CJ, Mesquita CH, Maranhão RC. Cancer Chemother Pharmacol; 2006 May; 57(5):624-30. PubMed ID: 16133527 [Abstract] [Full Text] [Related]
12. Paclitaxel associated with cholesterol-rich nanoemulsions promotes atherosclerosis regression in the rabbit. Maranhão RC, Tavares ER, Padoveze AF, Valduga CJ, Rodrigues DG, Pereira MD. Atherosclerosis; 2008 Apr; 197(2):959-66. PubMed ID: 18289548 [Abstract] [Full Text] [Related]
13. Cellular uptake mechanism and comparative evaluation of antineoplastic effects of paclitaxel-cholesterol lipid emulsion on triple-negative and non-triple-negative breast cancer cell lines. Ye J, Xia X, Dong W, Hao H, Meng L, Yang Y, Wang R, Lyu Y, Liu Y. Int J Nanomedicine; 2016 Apr; 11():4125-40. PubMed ID: 27601899 [Abstract] [Full Text] [Related]